Join our interactive online session tailored for emerging leaders in the pharma & biotech sectors moderated by Dr. Robert Franco. Ideal for those stepping into a supervisory role, this workshop offers valuable insights and strategies for success in your leadership position. This course will be held via Zoom on June 11, 13, 20, & 21st, 2024 from 11-3 pm EST. Course information coming soon! Sign up to be the first to know more at: https://csdd.tufts.edu/leadership or email Course Facilitator Sarah Wrobel.
Last month, Tufts CSDD’s PALADIN Consortium launched a Playbook and a Repository of Resources for patient advocacy groups (PAG) and biopharmaceutical companies to use in optimizing their collaborations. The Playbook provides process maps and forms to initiate and guide collaborations as well as template service and confidentiality agreements to expedite PAG-industry engagements. The Resource Repository contains over 100 identified and assessed best-in-class operational resources with links to the organizations that developed them. Both the Playbook and the Resource Repository are accessible on Paladinconsortium.org and they are available free of charge.
Investigative Site Participation Burden Tool Validation
Tufts CSDD has launched a new study to validate a tool designed to assess investigative site participation burden in clinical trials. Sponsors and CROs will apply the tool following a brief training exercise. Several companies have already joined the study. Please contact Maria Florez if your organization would like to learn more.
Introducing Our March/April Impact Report
Workplace Microaggressions Associated with Staff Turnover and Poor Performance
Our March/April Impact Report (Volume 26, Number 2) presents the results of a groundbreaking new study quantifying the incidence and impact of gender and racial microaggressions among drug development professionals. The report also documents the association between microaggressions and employee turnover and poor clinical team performance.
